SS Innovations International (NASDAQ: SSII) is positioning itself to capture a larger share of the global surgical robotics market as its SSi Mantra system gains traction in India and the company advances regulatory efforts in Europe and the United States. The company, which is an American firm headquartered in India, reported 224 SSi Mantra systems installed across 12 countries and a 143% year-over-year increase in robotic procedures during the second quarter of 2026. That growth underscores both the clinical adoption of the platform and the commercial opportunity that management is pursuing.
The most recent operational highlight came at Mohak Bariatrics and Robotics in Indore, where more than 50 robotic procedures were performed with the SSi Mantra in a single day. That milestone demonstrates the system's reliability and efficiency in a high-volume setting, which is critical for hospitals evaluating robotic surgery programs. For investors, it signals that the SSi Mantra is not just a niche product but a platform capable of supporting sustained, everyday use in busy surgical practices.
Financially, the company's second-quarter 2026 results reflect that momentum. Quarterly revenue rose 39% to $13.9 million, with system sales increasing 41% to $12.4 million. Installations reached 30 systems during the quarter, indicating that hospitals and surgical centers are continuing to adopt the technology. India remains the primary commercial market, but the company is also pursuing regulatory expansion into Europe and the United States. CE marking is targeted for the end of 2026, while FDA review of its 510(k) application is now expected by the end of the first quarter of 2027. These regulatory milestones could open significant new markets and diversify revenue streams beyond India.
SS Innovations is also developing telesurgery capabilities and expanding surgeon training as it seeks to grow utilization and establish its platform in additional markets. Telesurgery, which allows surgeons to perform procedures remotely, could be particularly transformative in regions with limited access to specialized care. By investing in training, the company is addressing a key barrier to adoption: the need for skilled surgeons who can confidently use the system. This dual approach of technology development and education supports long-term utilization growth and reinforces the company's vision to make robotic surgery affordable and accessible to a larger segment of the global population.
The implications of these developments extend beyond SS Innovations. As the company works toward CE marking and FDA clearance, it could intensify competition in the surgical robotics space, where established players have long dominated. A lower-cost, user-friendly system like the SSi Mantra could expand the overall market by making robotic surgery viable for more hospitals, including those in emerging economies. For patients, that could mean greater access to minimally invasive procedures with potentially better outcomes.
For investors tracking the surgical robotics sector, SS Innovations offers a growth story rooted in both clinical adoption and geographic expansion. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII. TechMediaWire, a specialized communications platform focused on pioneering technology companies, is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries. The platform also provides article and editorial syndication to 5,000+ outlets, enhanced press release enhancement to ensure maximum impact, and social media distribution via IBN to millions of social media followers. For more information, please visit TechMediaWire.
